-
Something wrong with this record ?
Exposure to nanoparticles of magnetite Fe3O4 in three different doses and their influence on selected respiratory parameters of bronchoalveolar lavage after intravenous instillation
M. Hurbánková, K. Volkovová, S. Černá, S. Wimmerová, Š. Moricová
Language English Country Czech Republic
Document type Journal Article
Digital library NLK
Source
NLK
Free Medical Journals
from 2004
ProQuest Central
from 2009-03-01 to 6 months ago
Medline Complete (EBSCOhost)
from 2006-03-01 to 6 months ago
Nursing & Allied Health Database (ProQuest)
from 2009-03-01 to 6 months ago
Health & Medicine (ProQuest)
from 2009-03-01 to 6 months ago
Public Health Database (ProQuest)
from 2009-03-01 to 6 months ago
ROAD: Directory of Open Access Scholarly Resources
from 1993
PubMed
38309704
DOI
10.21101/cejph.a7739
Knihovny.cz E-resources
- MeSH
- Bronchoalveolar Lavage MeSH
- Bronchoalveolar Lavage Fluid MeSH
- Administration, Intravenous MeSH
- Rats MeSH
- Nanoparticles * MeSH
- Ferrosoferric Oxide * MeSH
- Rats, Wistar MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: Due to nano-dimensions (less than 100 nm), can nanoparticles probably penetrate through various membranes and travel from the bloodstream to other organs in the body. The aim of our study was to find out whether NPs Fe3O4 (coated with sodium oleate) injected into the tail vein of laboratory Wistar rats pass through the bloodstream to the respiratory tract (in comparison with a control group); and if so whether increasing doses of NPs Fe3O4 have an escalating harmful effect on selected bronchoalveolar lavage (BAL) parameters. METHODS: Wistar rats were intravenously given 3 doses of the suspension of NPs Fe3O4 (0.1% LD50 = 0.0364, 1.0% = 0.364 and 10.0% = 3.64 mg/kg animal body weight). Seven days later, we sacrificed the animals under anaesthesia, performed bronchoalveolar lavage (BAL), and isolated the collected cells. Many inflammatory and cytotoxic BAL parameters were examined. RESULTS: Both inflammatory and cytotoxic BAL parameters affected by Fe3O4 suspension were changed compared to control results, but not all were statistically significant. Thus, the NPs Fe3O4 passed through the bloodstream to the respiratory tract and affected it. The highest concentration of NPs Fe3O4 (10%) had the most influence on BAL parameters (7 of 12 parameters). Only 3 parameters showed a pure dose dependence. CONCLUSION: We assume that the adverse effect of Fe3O4 NPs in our study is probably not correlated with the dose, but rather with the size of the particles or with their surface area.
Faculty of Public Health Slovak Medical University Bratislava Slovak Republic
Medical Faculty Slovak Medical University Bratislava Slovak Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24002920
- 003
- CZ-PrNML
- 005
- 20250312094530.0
- 007
- ta
- 008
- 240215s2023 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21101/cejph.a7739 $2 doi
- 035 __
- $a (PubMed)38309704
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Hurbánková, Marta $u Faculty of Public Health, Slovak Medical University, Bratislava, Slovak Republic $7 xx0077491
- 245 10
- $a Exposure to nanoparticles of magnetite Fe3O4 in three different doses and their influence on selected respiratory parameters of bronchoalveolar lavage after intravenous instillation / $c M. Hurbánková, K. Volkovová, S. Černá, S. Wimmerová, Š. Moricová
- 520 9_
- $a OBJECTIVES: Due to nano-dimensions (less than 100 nm), can nanoparticles probably penetrate through various membranes and travel from the bloodstream to other organs in the body. The aim of our study was to find out whether NPs Fe3O4 (coated with sodium oleate) injected into the tail vein of laboratory Wistar rats pass through the bloodstream to the respiratory tract (in comparison with a control group); and if so whether increasing doses of NPs Fe3O4 have an escalating harmful effect on selected bronchoalveolar lavage (BAL) parameters. METHODS: Wistar rats were intravenously given 3 doses of the suspension of NPs Fe3O4 (0.1% LD50 = 0.0364, 1.0% = 0.364 and 10.0% = 3.64 mg/kg animal body weight). Seven days later, we sacrificed the animals under anaesthesia, performed bronchoalveolar lavage (BAL), and isolated the collected cells. Many inflammatory and cytotoxic BAL parameters were examined. RESULTS: Both inflammatory and cytotoxic BAL parameters affected by Fe3O4 suspension were changed compared to control results, but not all were statistically significant. Thus, the NPs Fe3O4 passed through the bloodstream to the respiratory tract and affected it. The highest concentration of NPs Fe3O4 (10%) had the most influence on BAL parameters (7 of 12 parameters). Only 3 parameters showed a pure dose dependence. CONCLUSION: We assume that the adverse effect of Fe3O4 NPs in our study is probably not correlated with the dose, but rather with the size of the particles or with their surface area.
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a oxid železnato-železitý $7 D052203
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a bronchoalveolární laváž $7 D018893
- 650 12
- $a nanočástice $7 D053758
- 650 _2
- $a intravenózní podání $7 D061605
- 650 _2
- $a bronchoalveolární lavážní tekutina $7 D001992
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Volkovová, Katarína $u Medical Faculty, Slovak Medical University, Bratislava, Slovak Republic $7 xx0235004
- 700 1_
- $a Černá, Silvia $u Faculty of Public Health, Slovak Medical University, Bratislava, Slovak Republic $7 xx0147082
- 700 1_
- $a Wimmerová, Soňa $u Faculty of Public Health, Slovak Medical University, Bratislava, Slovak Republic $7 xx0234999
- 700 1_
- $a Moricová, Štefánia, $u Faculty of Public Health, Slovak Medical University, Bratislava, Slovak Republic $d 1954- $7 xx0146586
- 773 0_
- $w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 31, č. 4 (2023), s. 265-270
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38309704 $y Pubmed
- 910 __
- $a ABA008 $b B 1829 $c 562 $y p $z 0
- 990 __
- $a 20240215 $b ABA008
- 991 __
- $a 20250312094538 $b ABA008
- 999 __
- $a ok $b bmc $g 2283456 $s 1212656
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 31 $c 4 $d 265-270 $e - $i 1210-7778 $m Central European journal of public health $n Cent Eur J Public Health $x MED00001083
- LZP __
- $b NLK124 $a Pubmed-20240215